Authors
Loading...
This review discusses how nanobots improve targeted drug delivery in complex diseases, suggesting new strategies and implications for future therapies.
Bruno David (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: